Some studies showed a trend favoring older patients, but the difference was not statistically significant [ 133 , 134 ].
← all excerpts
Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective.
1
—
—